MRUS Merus N.V.
11.54
+0.18 (+2%)
Previous Close
11.36
Open
11.38
Price To Book
2.74
Market Cap
262545005
Shares
22,750,867
Volume
15,566
Short Ratio
Av. Daily Volume
48,663
NewsSee all news
SEC filingsSee all SEC filings
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19607175
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19604965
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19588046
- 6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16] 19571548
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19534785
Drug Information
Drug catalyst information is displayed when you hover over the stage bar graph.
Noted December 27, 2018 that NSCLC cohort enrolment is ongoing but will discontinue endometrial and ovarian cohorts.
MCLA-128
Gastric cancer, non-small cell lung cancer
Latest News
- Merus to Participate in Guggenheim Healthcare Talks Idea Forum
- Vertex's Kalydeco Wins Health Canada Nod to Treat CF in Kids
- Johnson & Johnson Is Selling These 2 Biotech Stocks
- Amarin Down on Lower '19 View, Posts Preliminary '18 Results
- Merus Announces IND Clearance for MCLA-145
- ProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals
- Merus Announces Strategic Collaboration with Betta Pharmaceuticals to Develop and Commercialize MCLA-129 in China
- The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO
- Merus Announces Financial Results for the Third Quarter 2018 and Provides Business Update
- Merus Announces Global Settlement and End to All Patent Litigation with Regeneron Pharmaceuticals
- Is Merus N.V. (MRUS) Going to Burn These Hedge Funds?
- Is Merus NV (NASDAQ:MRUS) A Financially Sound Company?
- Merus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
SEC Filings
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19607175
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19604965
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19588046
- 6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16] 19571548
- SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19534785
- SC 13G - Statement of acquisition of beneficial ownership by individuals 19506890
- D - Notice of Exempt Offering of Securities 19501794
- 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] 19501696
- 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] 181255194
- F-1 - Registration statement for certain foreign private issuers 181254942